

<!DOCTYPE html>

<link rel="stylesheet" type="text/css" href="./css/style.css">
<link media="screen,print" rel="stylesheet" type="text/css" href="./css/ai.css">

<div id="page-wrapper">
  <header id="header">
    <figure>
      <img class="grid-img-home" id="organos logo" src="./img/home/organos_logo_full.png" alt="organos logo"/>
    </figure>
      <div class="grid-item" style="text-align: right;">
        <nav class="nav-bar">
            <a href="./index.html">HOME</a>
            <a class="active" href="./services.html">SERVICES</a>
            <a href="#news">NEWS</a>
            <a href="./team.html">TEAM</a>
            <a href="./contact.html">CONTACT</a>
        </nav>
      </div>
  </header>

  <div id="zoomContainer">
    <div id="g-01_SERVICES_ICON-box" class="ai2html">
    	<!-- Artboard: Artboard_103 -->
    	<div id="g-01_SERVICES_ICON-Artboard_103" class="g-artboard" style="max-width: 592px;max-height: 317px" data-aspect-ratio="1.868" data-min-width="0">
    <div style="padding: 0 0 53.5452% 0;"></div>
    		<img id="g-01_SERVICES_ICON-Artboard_103-img" class="g-aiImg" alt="" src="./img/services/SERVICES_ICON-Artboard_103.png"/>
    		<div id="g-ai0-1" class="g-Layer_2 g-aiAbs" style="top:16.4044%;left:64.3332%;width:34.4595%;">
    			<p class="g-pstyle0">Drug Discovery and Development</p>
    		</div>
    		<div id="g-ai0-2" class="g-Layer_2 g-aiAbs" style="top:24.9221%;left:64.3962%;width:25.8446%;">
    			<p>Disease model development and target Identification to license compounds to Pharma.</p>
    		</div>
    		<div id="g-ai0-3" class="g-Layer_2 g-aiAbs" style="top:38.4873%;left:0.0001%;width:40.3716%;">
    			<p class="g-pstyle1">Contract Drug Development Research</p>
    		</div>
    		<div id="g-ai0-4" class="g-Layer_2 g-aiAbs" style="top:47.005%;left:0.0001%;width:33.9527%;">
    			<p>Preclinical drug development with a focus on late preclinical services, biomarker discovery, and clinical trials in cardiac tissue chips.</p>
    		</div>
    		<div id="g-ai0-5" class="g-Layer_2 g-aiAbs" style="top:67.1951%;left:64.1896%;width:35.473%;">
    			<p class="g-pstyle2">Organ Chip and Software Provider</p>
    		</div>
    		<div id="g-ai0-6" class="g-Layer_2 g-aiAbs" style="top:75.7128%;left:64.0837%;width:33.9527%;">
    			<p>Custom organ chips for Pharma Software licensing subscriptions and services.</p>
    		</div>
    	</div>
    </div>
  </div>
  <br>
  <br>
  <p style="margin: 2em; text-align: center">Organos provides a range of studies that can illuminate the dose effect
    of compounds on cardiac myocytes, ranging from acute safety pharmacology
    to chronic studies to understand long term cardiotoxicity.</p>


  <div class="container">
    <div class="grid-container">
      <figure>
        <img class="grid-img-services" src="./img/services/electrophysiological_EP_Testing.png" alt="Electrophysiological Testing"/>
      </figure>
      <div class="grid-item" style="margin: 10px; padding: 0;">
        <h2>Electrophysiological (EP) Testing</h2>
        <p>Organos can provide analysis of actional potential dynamics and calcium
          transients in our cardiac MPS using voltage sensitive dyes, a GCaMP
          calcium reporter, and high-resolution microscopy. Measurements can be
          performed at the baseline beat rate, as well as with electrically paced
          cells.  Organos provides critical information on compound induced changes
          to the action potential duration, calcium upstroke dynamics, and
          triangulation as a function of drug dose. <br><br>
          Organos uses a proprietary in silico framework to computationally invert
          these measurements into mechanism of action,  and provides estimated IC50
          values of ion channel binding for hERG, Peak Nav1.5, Late Nav 1.5,
          and Cav 1.2.  Our computational framework can also be used to project the results obtained in the MPS onto mature human phenotypes, as well as a canine cellular model to predict expected differential effects and dose dynamics across species and in adult native cells.
        </p>
      </div>
    </div>
   <hr>
    <div class="grid-container">
      <div class="grid-item">
        <h2>Muscle Twitch and Coupled EP-Twitch Dynamics</h2>
        <p>Through the use of high resolution imaging of the beating construct, changes
           in muscle twitch dynamics can be calculated in terms of length and
           magnitude of twitch strains in comparison to control chips. The upstroke
           and relaxation dynamics, as well as differential in observed changes in
           force generation compared to calcium transient can also be determined.
         </p>
     </div>
     <figure>
       <img class="grid-img-services" src="./img/services/Muscle_Twitch_and_Coupled_EP-Twitch_Dynamics.jpg" alt="muscle twitch"/>
     </figure>
   </div>

   <hr>

    <div class="grid-container">
      <figure>
        <img class="grid-img-services" src="./img/services/Chronic_Exposure.jpg" alt="Chronic Exposure"/>
      </figure>

      <div class="grid-item">
        <h2>Chronic Exposure</h2>
        <p>Due to the stability of the cardiac MPS systems, both EP and twitch
           studies can be done under long term (>24 hour) compound exposure to
            test for chronic exposure liability.  Long term analyses can be
            performed for  as described above and can be detailed to client's needs.
         </p>
       </div>


    </div>
    <hr>
    <div class="container">
      <h2>Let's test something together!</h2>
      <button class="btn" onclick="location.href='./contact.html';">Get in Touch</button>
      <figure>
        <img src="./img/home/organos_logo.png">
      </figure>
    </div>
